Soleno Therapeutics, Inc. (SLNO) Misses Q4 EPS by 6c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q4 EPS of ($0.33), $0.06 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c